| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8226543 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 8 Pages |
Abstract
MLC-based and Cerrobend-based SFGRT have comparable and encouraging response rates when used either in the palliative or curative setting. MLC-based SGFRT should allow clinics to more easily adopt this novel treatment approach for the treatment of bulky tumors.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Geoffrey M.D., Majid M. M.D., Noam M.D., Olga Ph.D., Jonathan Ph.D., Cedric X. Ph.D., William F. M.D.,